Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients-Reference-Cited by-同舟云学术

Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients

Published:2009-05-21 Issue:6 Volume:20 Page:1385-1392
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Noël Christian,Abramowicz Daniel,Durand Dominique,Mourad Georges,Lang Philippe,Kessler Michèle,Charpentier Bernard,Touchard Guy,Berthoux François,Merville Pierre,Ouali Nacera,Squifflet Jean-Paul,Bayle François,Wissing Karl Martin,Hazzan Marc

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference25 articles.

1. HLA Mismatches Remain Risk Factors for Acute Kidney Allograft Rejection in Patients Receiving Quadruple Immunosuppression With Anti-Interleukin-2 Receptor Antibodies

2. Kidney and Pancreas Transplantation in the United States, 1996?2005

3. Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials1

4. Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients

5. Efficacy of Anti-IL-2 Receptor Antibodies Compared to no Induction and to Antilymphocyte Antibodies in Renal Transplantation

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction immunosuppression strategies and outcomes post-lung transplant: A single center experience;Transplant Immunology;2024-08

2. IL-6 inhibition prevents costimulation blockade-resistant allograft rejection in T cell-depleted recipients by promoting intragraft immune regulation in mice;Nature Communications;2024-06-03

3. Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant;Transplant Immunology;2024-06

4. Immunosuppresseurs en transplantation rénale : mécanismes d’action et suivi biologique;Revue Francophone des Laboratoires;2024-03

5. Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk;Transplantation Proceedings;2023-09